Does prostate cancer treatment type affect mental health outcomes?

Overall, Black men were 24% less likely to receive or be prescribed a novel hormonal therapy agent compared with White men.

Amar Kishan, MD, highlights findings showing that MRI-guided SBRT is superior to CT-guided SBRT in localized prostate cancer.

The research projects are assessing combination therapies in advanced prostate cancer that include the use of relugolix.

“Localized prostate cancer is a very complicated disease space,” says Aaron A. Laviana, MD, MBA.

W. Kimryn Rathmell, MD, PhD, an internationally recognized expert in kidney cancer, is Chair of the Department of Medicine and Physician-in-Chief at Vanderbilt University Medical Center.

In the second article of this series, Benjamin H. Lowentritt, MD, FACS, provides clinical insights on micronized abiraterone as a treatment for patients with prostate cancer.